DeepScan Diagnostics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Series 2

  • Latest Deal Amount
  • $3.5M

  • Investors
  • 4

DeepScan Diagnostics General Information

Description

Operator of a precision veterinary diagnostics platform intended to support early disease detection and ongoing health monitoring in dogs. The company offers blood-based cell-free DNA biomarker testing and canine health data analysis to detect signs of cancer, inflammation, and organ damage, enabling veterinarians and pet owners to identify potential health conditions earlier and make informed treatment decisions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Elimäenkatu 17-19
  • 00510 Helsinki
  • Finland
+358 050
Primary Industry
Other Services (B2C Non-Financial)
Other Industries
Diagnostic Equipment
Vertical(s)
Corporate Office
  • Elimäenkatu 17-19
  • 00510 Helsinki
  • Finland
+358 050

DeepScan Diagnostics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

DeepScan Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series 2) 22-Apr-2026 $3.5M Completed Generating Revenue
3. Early Stage VC 28-Oct-2025 Completed Generating Revenue
2. Early Stage VC (Series 1) 19-Nov-2024 $2.15M $2.15M Completed Generating Revenue
1. Grant 07-Feb-2024 $16.3K Completed Generating Revenue
To view DeepScan Diagnostics’s complete valuation and funding history, request access »

DeepScan Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series 2 Preferred Shares
Seed Shares
To view DeepScan Diagnostics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

DeepScan Diagnostics Patents

DeepScan Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260265830-A1 Method of measuring cell-free dna in blood of canis familiaris Pending 04-Mar-2025
JP-2025160560-A Biological state estimation system, biological state estimation method, program, and recording medium Pending 10-Apr-2024

DeepScan Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

DeepScan Diagnostics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Harjavalta Family Office Minority
Business Finland Government Minority
Calm/Storm Ventures Venture Capital Minority
Runar Bäckström Foundation Limited Partner
To view DeepScan Diagnostics’s complete investors history, request access »

DeepScan Diagnostics FAQs

  • When was DeepScan Diagnostics founded?

    DeepScan Diagnostics was founded in 2022.

  • Where is DeepScan Diagnostics headquartered?

    DeepScan Diagnostics is headquartered in Helsinki, Finland.

  • What is the size of DeepScan Diagnostics?

    DeepScan Diagnostics has 12 total employees.

  • What industry is DeepScan Diagnostics in?

    DeepScan Diagnostics’s primary industry is Other Services (B2C Non-Financial).

  • Is DeepScan Diagnostics a private or public company?

    DeepScan Diagnostics is a Private company.

  • What is DeepScan Diagnostics’s current revenue?

    The current revenue for DeepScan Diagnostics is .

  • How much funding has DeepScan Diagnostics raised over time?

    DeepScan Diagnostics has raised $7.71M.

  • Who are DeepScan Diagnostics’s investors?

    Harjavalta, Business Finland, Calm/Storm Ventures, and Runar Bäckström Foundation have invested in DeepScan Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process